Vitamin D: A Key Factor in Prostate Health
Lana Lekić *
Faculty of Health Studies, University of Sarajevo,Sarajevo, Bosnia and Herzegovina.
Ervin Alibegović
University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
Jasna Rahimić
Mixed Middle school of Chemistry, Tuzla, Bosnia and Herzegovina.
Bojan Pavlović
Faculty of Sport and Physical Education Sarajevo, University of East Sarajevo, Bosnia and Herzegovina.
Ana Pavlović
MF Master Fizikal, Bojan Pavlovic, Karadjordjeva 6, Bosnia and Herzegovina.
Aida Hamzić-Mehmedbašić
Nephrology Clinic, Clinical Centre University of Sarajevo, Bosnia and Herzegovina.
Aldijana Mahmutović Milićević
Faculty of Pharmacy, University of Tuzla, Tuzla, Bosnia and Herzegovina.
Nehra Mosorović
Faculty of Medicine, University of Tuzla, Bosna and Herzegovina.
Emil Mujkić
University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
Asja Šarić
Faculty of Pharmacy, University of Tuzla, Tuzla, Bosnia and Herzegovina.
Dino Alibegović
Faculty of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.
*Author to whom correspondence should be addressed.
Abstract
This study examines the correlation between vitamin D levels and the severity of symptoms and quality of life in patients with benign prostatic hyperplasia (BPH). A total of 125 participants were categorized based on their prostate symptoms (mild, moderate, and severe) and vitamin D levels (deficient, insufficient, and optimal). Among those with mild symptoms (n=60), 37.93% were vitamin D deficient, 44.11% had insufficient vitamin D, and 54.83% had optimal levels. For moderate symptoms (n=55), 44.82% were deficient, 47.05% had insufficient, and 41.93% had optimal vitamin D levels. In severe cases (n=10), 17.04% were deficient, 8.82% had insufficient, and 3.22% had optimal vitamin D levels. Overall, 23.02% of participants were deficient, 27.02% had insufficient, and 49.6% had optimal vitamin D levels. Quality of life assessments revealed that 56.8% of participants reported a good quality of life, with 46.66% of these being vitamin D deficient, 57.57% insufficient, and 61.29% optimal. An indifferent quality of life was noted by 29.6% of participants, with 28.57% deficient, 27.27% insufficient, and 29.03% optimal vitamin D levels. A very poor quality of life was reported by 13.6% of participants, with 21.42% deficient, 15.15% insufficient, and 9.67% optimal vitamin D levels. These results indicate a potential association between higher vitamin D levels and improved prostate symptoms and quality of life in BPH patients. Further research is needed to establish causality and underlying mechanisms.
Keywords: Vitamin D, benign prostatic hyperplasia, prostate health, quality of life